| Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial S Ross, A Bossis, J Guss, G Agin-Liebes, T Malone, B Cohen, ... Journal of psychopharmacology 30 (12), 1165-1180, 2016 | 1499 | 2016 |
| Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis AB Belser, G Agin-Liebes, TC Swift, S Terrana, N Devenot, HL Friedman, ... Journal of Humanistic Psychology 57 (4), 354-388, 2017 | 283 | 2017 |
| Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer GI Agin-Liebes, T Malone, MM Yalch, SE Mennenga, KL Ponté, J Guss, ... Journal of psychopharmacology 34 (2), 155-166, 2020 | 277 | 2020 |
| Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study BT Anderson, A Danforth, R Daroff, C Stauffer, E Ekman, G Agin-Liebes, ... EClinicalMedicine 27, 2020 | 155 | 2020 |
| Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress TC Swift, AB Belser, G Agin-Liebes, N Devenot, S Terrana, HL Friedman, ... Journal of Humanistic Psychology 57 (5), 488-519, 2017 | 138 | 2017 |
| Individual experiences in four cancer patients following psilocybin-assisted psychotherapy TC Malone, SE Mennenga, J Guss, SK Podrebarac, LT Owens, AP Bossis, ... Frontiers in pharmacology 9, 335252, 2018 | 88 | 2018 |
| Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening … S Ross, G Agin-Liebes, S Lo, RJ Zeifman, L Ghazal, J Benville, ... ACS pharmacology & translational science 4 (2), 553-562, 2021 | 72 | 2021 |
| Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes G Agin-Liebes, TF Haas, R Lancelotta, MV Uthaug, JG Ramaekers, ... ACS Pharmacology & Translational Science 4 (2), 543-552, 2021 | 58 | 2021 |
| Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the United States AK Davis, G Agin-Liebes, M España, B Pilecki, J Luoma Journal of psychoactive drugs 54 (4), 309-318, 2022 | 53 | 2022 |
| Participant reports of mindfulness, posttraumatic growth, and social connectedness in psilocybin-assisted group therapy: An interpretive phenomenological analysis G Agin-Liebes, E Ekman, B Anderson, M Malloy, A Haas, J Woolley Journal of Humanistic Psychology, 00221678211022949, 2021 | 32 | 2021 |
| Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca G Agin-Liebes, R Zeifman, JB Luoma, EL Garland, WK Campbell, B Weiss Journal of Psychopharmacology 36 (3), 295-308, 2022 | 28 | 2022 |
| An improved, practical, and scalable five-step synthesis of psilocybin AM Sherwood, P Meisenheimer, G Tarpley, RB Kargbo Synthesis 52 (05), 688-694, 2020 | 20 | 2020 |
| The need for establishing best practices and gold standards in psychedelic medicine A Feduccia, G Agin-Liebes, CM Price, N Grinsell, S Paradise, DM Rabin Journal of Affective Disorders 332, 47-54, 2023 | 11 | 2023 |
| Psilocybin for the treatment of depression: a promising new pharmacotherapy approach G Agin-Liebes, AK Davis Disruptive Psychopharmacology, 125-140, 2021 | 7 | 2021 |
| The role of self-compassion in psilocybin-assisted motivational enhancement therapy to treat alcohol dependence: A randomized controlled trial G Agin-Liebes Palo Alto University, 2020 | 6 | 2020 |
| Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone G Agin-Liebes, AS Huhn, EC Strain, GE Bigelow, MT Smith, RR Edwards, ... Drug and alcohol dependence 226, 108869, 2021 | 5 | 2021 |
| Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis. G Agin-Liebes, EM Nielson, M Zingman, K Kim, A Haas, LT Owens, ... Psychology of Addictive Behaviors, 2023 | 4 | 2023 |
| Race, ethnic, and sex differences in prevalence of and trends in hallucinogen consumption among lifetime users in the United States between 2015 and 2019 AK Davis, BJ Arterberry, Y Xin, G Agin-Liebes, C Schwarting, MT Williams Frontiers in Epidemiology 2, 876706, 2022 | 4 | 2022 |
| Psilocybin. S Ross, S Franco, C Reiff, G Agin‑Liebes The Guilford Press, 2021 | 3 | 2021 |
| Assessing the acceptability of yoga among patients with and without chronic pain enrolled in a licensed opioid treatment program E Ahmadi, C Evans, G Agin-Liebes, DA Tompkins International journal of yoga therapy 32 (2022), Article 3, 2022 | 2 | 2022 |
Alexander B. BelserYale UniversityVerified email at yale.edu
